Serina Therapeutics, Inc. (SER)
AMEX·Healthcare·Biotechnology
$1.83
+1.67%
Mkt Cap $17.15M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$0.50 | -$0.31 | +38.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.47 | -$0.45 | +4.26% | — | — |
| Q3 2025 Aug 11, 2025 | — | $130.00K | — | -$0.36 | -$0.66 | -83.33% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.62 | -$0.49 | +20.97% | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | $0.42 | -$0.27 | -164.29% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | — | $0.13 | — | — | — |
| Q3 2024 Aug 9, 2024 | — | $51.00K | — | — | $0.51 | — | — | — |
| Q2 2024 May 14, 2024 | — | $5.00K | — | — | -$3.38 | — | — | — |
| Q1 2024 Mar 22, 2024 | — | $56.00K | — | — | -$3.20 | — | — | — |
| Q4 2023 Nov 14, 2023 | — | $9.00K | — | — | -$0.14 | — | — | — |
| Q3 2023 Sep 29, 2023 | — | $67.00K | — | — | -$5.01 | — | — | — |
| Q1 2023 Mar 30, 2023 | — | $10.00K | — | — | -$3.04 | — | — | — |
| Q4 2022 Dec 30, 2022 | — | $8.00K | — | — | -$2.51 | — | — | — |
| Q3 2022 Sep 29, 2022 | — | $9.00K | — | — | -$2.26 | — | — | — |
| Q2 2022 Jun 29, 2022 | — | $12.00K | — | — | -$2.43 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | $5.00K | — | — | -$2.51 | — | — | — |
| Q4 2021 Dec 30, 2021 | — | $2.00K | — | — | -$2.00 | — | — | — |
| Q3 2021 Sep 29, 2021 | — | $24.00K | — | — | -$1.81 | — | — | — |
| Q2 2021 Jun 29, 2021 | — | $37.00K | — | — | -$2.29 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $56.00K | — | — | -$1.95 | — | — | — |